Rapid Micro Biosystems, Inc. (RPID)
NASDAQ: RPID · IEX Real-Time Price · USD
0.670
-0.015 (-2.19%)
Jul 26, 2024, 3:39 PM EDT - Market closed

Rapid Micro Biosystems Revenue

Rapid Micro Biosystems had revenue of $5.61M in the quarter ending March 31, 2024, with 11.44% growth. This brings the company's revenue in the last twelve months to $23.10M, up 28.25% year-over-year. In the year 2023, Rapid Micro Biosystems had annual revenue of $22.52M with 31.44% growth.

Revenue (ttm)
$23.10M
Revenue Growth
+28.25%
P/S Ratio
1.24
Revenue / Employee
$119,663
Employees
193
Market Cap
28.72M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202322.52M5.39M31.44%
Dec 31, 202217.13M-6.10M-26.25%
Dec 31, 202123.23M7.15M44.50%
Dec 31, 202016.08M-435.00K-2.63%
Dec 31, 201916.51M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Accelerate Diagnostics 12.17M
Bolt Biotherapeutics 11.32M
Palatin Technologies 5.90M
Renalytix 2.22M
Longeveron 978.00K
Revenue Rankings